Cardiovascular Benefits: Nattokinase vs. Vitamin D vs. Vitamin K2
Cardiovascular Benefits: Nattokinase vs. Vitamin D vs. Vitamin K2
Perplexity AI April 2026
| Cardiovascular Domain | Nattokinase | Vitamin D | Vitamin K2 |
|---|---|---|---|
| Anti-clotting / Fibrinolysis | ★★★★★ Direct fibrin dissolution; degrades fibrinogen, Factor VII, Factor VIII; inhibits PAI-1; ~4× more effective than plasmin nature | ★★☆☆☆ Reduces thrombin generation and clot density when correcting deficiency; no direct fibrinolytic action pmc.ncbi.nlm.nih | ★☆☆☆☆ Minimal direct effect; K2-MK-7 did not significantly affect thrombin generation in animal models sciencedirect |
| Blood Pressure Reduction | ★★★★☆ Consistent clinical evidence: −3.45 mmHg systolic, −2.32 mmHg diastolic via ACE inhibition pmc.ncbi.nlm.nih | ★★☆☆☆ Modest effect; limited to deficient individuals via renin-angiotensin system modulation cdc | ★★★☆☆ MK-7 (180 µg/day) reduced BP by ~3% in post-menopausal women with high arterial stiffness; benefit mainly in high-risk groups pmc.ncbi.nlm.nih |
| Arterial Calcification | ★★☆☆☆ Reduces plaque area indirectly through fibrinolytic and lipid-lowering effects frontiersin | ★★☆☆☆ Stimulates MGP synthesis (the anti-calcification protein), but depends on K2 to activate it pmc.ncbi.nlm.nih | ★★★★☆ Activates Matrix Gla Protein (MGP), the body's primary calcification inhibitor; Rotterdam Study showed 50% reduction in arterial calcification with high K2 dietary intake nutraceuticalbusinessreview |
| Arterial Stiffness | ★★☆☆☆ Indirect benefit via plaque reduction and fibrinolysis frontiersin | ★★☆☆☆ Deficiency linked to impaired arterial flexibility sciencedirect | ★★★★☆ 3-year MK-7 RCT showed significant reduction in pulse wave velocity and restored vessel elasticity nutraceuticalbusinessreview |
| Atherosclerotic Plaque | ★★★★★ High-dose (10,800 FU/day) trials showed 66–95% reduction in carotid plaque over 12 months gertitashkomd | ★★☆☆☆ Anti-inflammatory benefits slow plaque progression; no direct plaque dissolving pmc.ncbi.nlm.nih | ★★★☆☆ K2 slowed non-calcified plaque volume progression in combination with D3; reduced plaque in hypercholesteremic animal models pmc.ncbi.nlm.nih |
| Lipid Lowering (LDL/TG) | ★★★★☆ Directly lowers LDL and triglycerides in multiple clinical trials pmc.ncbi.nlm.nih | ★★☆☆☆ Inconsistent evidence; modest or no direct effect on lipids pmc.ncbi.nlm.nih | ★★☆☆☆ Weak lipid-lowering effect; primary benefit is calcium redirection, not lipid reduction openaccessjournals |
| Endothelial Function | ★★★★☆ Suppresses NLRP3 inflammasome and necroptosis in vascular cells pubmed.ncbi.nlm.nih | ★★★☆☆ Strongly linked to endothelial stability; deficiency impairs arterial flexibility sciencedirect | ★★★☆☆ K2-MK-7 improves nitric oxide–dependent vasodilation sciencedirect |
| Vascular Inflammation | ★★★★☆ Promotes autophagy; reduces vascular inflammatory markers pubmed.ncbi.nlm.nih | ★★★★☆ Strong systemic anti-inflammatory via VDR-mediated pathways sciencedirect | ★★★☆☆ Reduces dp-ucMGP (marker of vascular inflammation risk); anti-inflammatory via MGP activation openheart.bmj |
| Heart Valve Calcification | ★☆☆☆☆ No evidence | ★★☆☆☆ Supports MGP synthesis but not sufficient alone; combined K2+D3 RCT did not slow aortic valve calcification in established disease ahajournals | ★★☆☆☆ Promising mechanistically; however large RCTs (AVADEC trial) found no significant slowing of aortic valve calcification once established ahajournals |
| Strength of Clinical Evidence | Moderate — solid RCTs for BP and lipids; large-dose plaque trials promising but limited pmc.ncbi.nlm.nih | Moderate — strongest for inflammation/endothelium; BP and clotting evidence mixed pubmed.ncbi.nlm.nih | Moderate — strong observational data (Rotterdam, Prospect studies); RCT results mixed, especially for valvular calcification nutraceuticalbusinessreview |
Key Synergies
The three are highly complementary rather than redundant. Vitamin D stimulates synthesis of Matrix Gla Protein, but K2 is required to activate it — making them synergistic for anti-calcification. Nattokinase handles the acute clotting and fibrinolytic side that neither vitamin addresses. A combined D3 + K2 + nattokinase protocol targets the cardiovascular system from three distinct angles: clot dissolution, endothelial/inflammatory health, and calcium management. pmc.ncbi.nlm.nih
Nattokinase - Perplexity AI April 2026
Nattokinase is a powerful fibrinolytic enzyme derived from natto (fermented soybeans) that has been extensively studied for its cardiovascular and anti-clotting benefits. Here's a breakdown of what the research shows:
What It Is & How It Works
Nattokinase directly dissolves fibrin, the protein scaffold that forms blood clots. It also cleaves and inactivates plasminogen activator inhibitor (PAI-1) — a key blocker of the body's own clot-dissolving system — thereby enhancing natural fibrinolysis. In vitro studies show it breaks down cross-linked fibrin 6 times more efficiently than plasmin, and in animal models it is about 4 times more effective than plasmin at dissolving a thrombus. mskcc
Anti-Clotting & Blood Flow
Nattokinase reduces several clotting factors simultaneously, acting through multiple pathways at once. A clinical study of 45 people found that 4,000 FU/day for eight weeks reduced multiple blood clotting factors — in healthy individuals, those with cardiovascular disease, and dialysis patients alike. It also inhibits platelet aggregation by blocking thromboxane formation, making it useful for reducing risk of deep vein thrombosis (DVT) and pulmonary embolism. nature
Blood Pressure Reduction
This is nattokinase's most consistently proven benefit in clinical trials. A meta-analysis found supplementation reduced systolic blood pressure by 3.45 mmHg and diastolic by 2.32 mmHg compared to placebo. The mechanism appears to involve inhibition of angiotensin-converting enzyme (ACE) and reduced plasma angiotensin II levels. droracle
Lipid & Atherosclerosis Effects
Large-scale clinical trials have confirmed that nattokinase improves lipid profiles and reduces atherosclerotic plaque area and intima-media thickness. Compared to statins and fibrates, it offers a multifaceted lipid-lowering mechanism with a lower side-effect profile, and may work synergistically when combined with red yeast rice or lifestyle interventions. pmc.ncbi.nlm.nih
Neuroprotective & Anti-Inflammatory Effects
Animal studies suggest nattokinase may degrade amyloid plaques associated with Alzheimer's disease, though human trials have not yet been conducted. Recent research also shows it reduces vascular inflammation by promoting autophagy and suppressing inflammasome activity, potentially slowing atherosclerosis progression. sciencedirect
Key Considerations
- Dosing: Most studies use 2,000–4,000 FU (fibrinolytic units) per day biogena
- Caution with anticoagulants: Since it thins the blood, combining it with warfarin, aspirin, or other blood thinners increases bleeding risk webmd
- Oral bioavailability: It is absorbed intact through the gut, which is notable for a protein enzyme nbihealth
- A 2026 randomized trial is currently investigating its effects on inflammation and cardiovascular risk markers in patients with hypertension and dyslipidemia centerwatch
400+ suppliers of Nattokinase on Amazon
Some cost only 12 cents per pill
Even a Single Dose of Nattokinase Thins Blood and Breaks Down Clots
Includes 13 minute interview with the author of the book:
"The Clot Thickens: The Enduring Mystery of Heart Disease,"